Nimotuzumab and radiotherapy in children and adolescents with brain stem glioma: Preliminary results from a Phase II study. T. Crombet 1, R. Cabanas 2,
022 cheson-2007-criteria-icon-medical-imaging
Reolysin
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven,
Hepatocellular Carcinoma: Progress at last Alan P. Venook, M.D. University of California, San Francisco.
Results from a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy 1 Final.
LUNG CANCER
Metastatic Renal Cell Carcinoma What’s Hot In The Treatment Of Renal Cell Carcinoma And Is There Hope? Cora N. Sternberg, MD, FACP Chairman, Department.
M. Ychou 1 , F. Desseigne 2 , R. Guimbaud 3 , M. Ducreux 4 , O. Bouché 5 ,
1 Coiffier B et al. J Clin Oncol 2012;30(6):631-6 . Proc ASH 2011;Abstract 591.
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer ( mCRC )
RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC.
